LRMR
NASDAQ · Biotechnology
Larimar Therapeutics Inc
$3.21
+0.14 (+4.39%)
EPS Surprise History
Earnings Summary
Beats (Last 2)
1/2
Avg Surprise
+1.0%
Consecutive Beats
1 quarter
Latest EPS
$-0.31
History
2 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Q3 FY2026 | $-0.39 | — | — | — | — |
| May 14, 2026 | Q2 FY2026 | $-0.55 | $-0.31 | +$0.24 | +43.2% | Beat |
| May 7, 2026 | Q2 FY2026 | $-0.57 | — | — | — | — |
| Mar 19, 2026 | Q1 FY2026 | $-0.52 | $-0.73 | -$0.21 | -41.2% | Miss |
| Mar 18, 2026 | Q1 FY2026 | $-0.52 | — | — | — | — |